Regardless of the outcome of this debate, one thing is clear -- prostate cancer screening is not going away anytime soon.
Even Barry admitted that on an individual level, it is impossible to identify which men may have been overdiagnosed and require no treatment for the disease. Given this fact, many believe that recommending that men skip their PSA screenings would be a premature step.
Still, Barry noted, more needs to be done to weed out those men for whom prostate cancer will never be a problem.
"What's becoming increasingly clear is that men who elect regular PSA testing to screen for prostate cancer substantially increase their risk of having to deal with a diagnosis of prostate cancer, including how to treat it, and men who would have eventually faced a diagnosis of prostate cancer anyway will have to do so much earlier," he said.